NPRR.F logo

Nipro OTCPK:NPRR.F Stock Report

Last Price

US$8.50

Market Cap

US$1.2b

7D

0%

1Y

n/a

Updated

21 Jun, 2022

Data

Company Financials +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Nipro Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nipro
Historical stock prices
Current Share PriceJP¥8.50
52 Week HighJP¥8.50
52 Week LowJP¥8.50
Beta0.47
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-43.71%

Recent News & Updates

Recent updates

Shareholder Returns

NPRR.FUS Medical EquipmentUS Market
7D0%-1.2%1.2%
1Yn/a-0.9%20.8%

Return vs Industry: Insufficient data to determine how NPRR.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how NPRR.F performed against the US Market.

Price Volatility

Is NPRR.F's price volatile compared to industry and market?
NPRR.F volatility
NPRR.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.8%
Market Average Movement5.7%
10% most volatile stocks in US Market15.4%
10% least volatile stocks in US Market2.9%

Stable Share Price: NPRR.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NPRR.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
194735,251Yoshihiko Sanowww.nipro.co.jp

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company’s Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations.

Nipro Corporation Fundamentals Summary

How do Nipro's earnings and revenue compare to its market cap?
NPRR.F fundamental statistics
Market capUS$1.24b
Earnings (TTM)US$98.79m
Revenue (TTM)US$3.63b

12.6x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NPRR.F income statement (TTM)
RevenueJP¥494.79b
Cost of RevenueJP¥345.52b
Gross ProfitJP¥149.27b
Other ExpensesJP¥135.82b
EarningsJP¥13.46b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 09, 2022

Earnings per share (EPS)82.50
Gross Margin30.17%
Net Profit Margin2.72%
Debt/Equity Ratio267.8%

How did NPRR.F perform over the long term?

See historical performance and comparison

Dividends

3.0%

Current Dividend Yield

33%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.